Bleakley Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bleakley Financial Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.82M	Sell	17,944 -354	-2%	-$192K	0.14%	120
2025 Q4	$10.6M	Buy	18,298 +2,873	+19%	+$1.62M	0.18%	94
2025 Q3	$7.48M	Buy	15,425 +1,500	+11%	+$698K	0.17%	106
2025 Q2	$5.65M	Sell	13,925 -540	-4%	-$226K	0.14%	135
2025 Q1	$7.2M	Buy	14,465 +2,597	+22%	+$1.41M	0.23%	83
2024 Q4	$6.17M	Buy	11,868 +812	+7%	+$446K	0.19%	92
2024 Q3	$6.84M	Sell	11,056 -13,617	-55%	-$8.06M	0.21%	84
2024 Q2	$13.6M	Sell	24,673 -164	-0.7%	-$94K	0.39%	44
2024 Q1	$14.4M	Sell	24,837 -5,880	-19%	-$3.3M	0.42%	41
2023 Q4	$16.3M	Sell	30,717 -965	-3%	-$467K	0.52%	36
2023 Q3	$16M	Buy	31,682 +3,713	+13%	+$1.98M	0.57%	34
2023 Q2	$14.6M	Sell	27,969 -1,089	-4%	-$588K	0.46%	41
2023 Q1	$16.7M	Buy	29,058 +718	+3%	+$405K	0.56%	32
2022 Q4	$15.6M	Buy	+28,340	New	+$15M	0.56%	34

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bleakley Financial Group's TMO Position: Q1 2026 in Review

Bleakley Financial Group reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q1 2026, selling an estimated $192K and leaving 17,944 shares worth $8.82M. The position accounts for 0.14% of the portfolio, ranked #120.

Bleakley Financial Group first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $16.7M in Q1 2023. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Bleakley Financial Group held 17,944 shares of Thermo Fisher Scientific worth $8.82M as of Q1 2026.
Bleakley Financial Group sold 354 Thermo Fisher Scientific shares in Q1 2026, an estimated $192K.
Thermo Fisher Scientific made up 0.14% of Bleakley Financial Group's portfolio in Q1 2026, its #120 holding.
Bleakley Financial Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
Bleakley Financial Group's Thermo Fisher Scientific position peaked at $16.7M in Q1 2023.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Bleakley Financial Group's 13F filing for Q1 2026, filed 4 May 2026.